Bonafide Announces Acquisition of SAM-e Nutritional Technology

Three-times more powerful, patented formulation of S-adenosylmethionine (SAM-e) further deepens Company's pipeline

NEW YORK, April 20, 2022 /PRNewswire/ -- Bonafide®, the women's healthcare company that is pioneering a new and more natural approach to managing menopause symptoms with first-of-its-kind, evidence-based, over-the-counter medical products, has announced its acquisition of a patented, enhanced formulation of S-adenosylmethionine (SAM-e), with triple the bioavailability of competitor products. This acquisition boosts Bonafide's patent holdings to more than 50 issued and pending patents that it owns or exclusively licenses and exemplifies its strategy of bringing innovative R&D to the women's health space.

SAM-e is a naturally occurring substance that is a key nutrient, widely used by the body. The SAMe composition, referred to as MSI-195, is a high bioavailability formulation of the dietary ingredient SAM-e, which is primarily used as a dietary supplement to support mood, joint health, and liver function. As part of this acquisition, Bonafide owns all assets and world-wide patents related to the supplement.

Jim Komorowski, Bonafide's Chief Science Officer said, "This unique and potent form of SAM-e has been studied as a potential pharmaceutical product over the past decade with a significant amount of safety, pre-clinical and clinical research supporting the enhanced bioavailability of this compound. We are very enthusiastic about MSI-195 because it has the potential to help women in a number of important areas, including mood. This technology will be added to Bonafide's already robust pipeline that includes products for overactive bladder, sleep and other symptoms that are critical to women's health."                                            

With the dietary supplements market expected to reach $128 billion by 2028, the demand for quality, efficacious products is predicted to be the driver behind this growth in the coming years.

Bonafide's commitment to identifying and studying natural products that target the same mechanistic pathways as pharmaceutical drugs, is supported by the company's multimillion-dollar investments each year in technology and clinical trials. Bonafide's portfolio of proprietary, patented ingredients and products set a strong scientific foundation for its work with physicians to develop natural solutions for common patient needs. With the completion of this acquisition, Bonafide plans to continue rigorous clinical trials to leverage the patented ingredient into future Bonafide products.

Alyssa Dweck, MD, Bonafide's Chief Medical Officer said, "During my over 25 years in practice as an OB-GYN, I have seen that women want and need non-drug, natural alternatives for the treatment of symptoms from hormonal changes during menopause. Bonafide is not only bringing unique and naturally powerful products to market, but also leveraging its national team of physician educators to bring this important information directly to mainstream doctors and other healthcare providers. In fact, Bonafide regularly interacts with more than 11,000 healthcare providers, including many of the top menopause specialists in the US."

Since launching in 2018, Bonafide has expanded its suite of products to include five signature natural menopause symptom relief solutions, in addition to a line of best-selling essential everyday vitamins. Today, Bonafide has over 120,000 active customers and a 92% monthly customer retention rate, making Bonafide an industry-leading developer of women's menopause products.

For more information on Bonafide, visit hellobonafide.com.

About Bonafide
Bonafide Health was launched with a simple mission in mind: to provide women with novel, safe and highly effective treatment options for relief from symptoms throughout their menopause journey. As part of Bonafide's scientific research and product development process, the brand prides itself on its deep understanding of the biological and physiological changes that affect women due to hormonal fluctuations experienced as they age. Trusted by more than 11,000 health care professionals, Bonafide provides first-of-its-kind, evidence-based solutions developed from naturally derived ingredients that are hormone-free and drug-free.

SOURCE Bonafide Health

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED